Ep190: Neil Kumar on Building a Rare Disease Drug Company
The Long Run with Luke Timmerman
00:00
Time and cost to develop Acoramidus
Neil states the program took about eight years and under $300 million to take Acoramidus from discovery to approval.
Play episode from 45:27
Transcript
